InvestorsHub Logo

ariadndndough

02/03/11 7:27 AM

#5464 RE: biotech_researcher #5462

What people need to understand last year after merger with sgp
Mrk went thru the pipeline and made cuts on what they were
Not going go advance
With rids meeting it's endpoints and now that it's in mrk report there
Should be no talk of mrk not being on board with rida

Keep an eye on clinicaltrials. As this is were I expect you will see othr
Trials come on board

Bring on ASCO

gdollasign

02/03/11 7:30 AM

#5465 RE: biotech_researcher #5462

Yep, they could have put most anything in those business highlights....but they chose little ole Rida.

I want to know why we arent trading at $8. Hell for that matter DNDN doesnt offer any great drugs and look at that thing. I guess we are just here "on the ground floor" and I will happy with that for now.